Givaudan (GVDNY)
(Delayed Data from OTC)
$96.86 USD
+1.80 (1.90%)
Updated Jul 22, 2024 02:41 PM ET
1-Strong Buy of 5 1
F Value B Growth A Momentum C VGM
Givaudan SA (GVDNY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$98.00 | $98.00 | $98.00 | 3.09% |
Price Target
Only one analyst offered a short-term price target of $98.00 for Givaudan SA. This represents an increase of 3.09% from the last closing price of $95.06.
Analyst Price Targets (1 )
Broker Rating
Givaudan SA currently has an average brokerage recommendation (ABR) of 3.13 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 3.13 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, one is Strong Buy, representing 12.5% of all recommendations. A month ago, Strong Buy represented 12.5%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/GVDNY.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 4 | 4 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 3.13 | 3.13 | 3.13 | 2.88 | 2.88 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/19/2024 | Not Identified | Not Identified | Moderate Sell | Moderate Sell |
6/5/2024 | Not Identified | Not Identified | Strong Buy | Hold |
4/18/2024 | UBS | Geoff Haire | Strong Sell | Hold |
3/25/2024 | Goldman Sachs | Georgina Fraser | Not Available | Strong Buy |
3/20/2024 | Berenberg Bank | Samantha Darbyshire | Hold | Hold |
10/10/2023 | Not Identified | Not Identified | Not Available | Strong Sell |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.13 |
ABR (Last week) | 3.13 |
# of Recs in ABR | 8 |
Average Target Price | $98.00 |
LT Growth Rate | 11.90% |
Industry | Chemical - Specialty |
Industry Rank by ABR | 76 of 252 |
Current Quarter EPS Est: | NA |